The difficulty of getting oncology products to market was emphasized in a recent New York Times article , along with a good lesson about needlessly risky study execution. The article... Read more
Lilly’s renovation plans are big news in pharma this week—starting January 1, 2010, the company will adopt a majorly restructured operating model in hopes of reducing cost, boosting... Read more
The New York Times ’ recent article on Boeing’s delays getting its new 787 Dreamliner off the ground should hit close to home for many of us in the drug development industry.... Read more
This week’s New York Times article “For Profit, Industry Seeks Cancer Drugs” is a good reminder of just how complex oncology drug development has become. Cancer drugs are so... Read more
